Combining the principles of evolution with artificial intelligence (AI), scientists have proposed a new way to predict the chance of prostate cancer returning. In a recent study, they harnessed ...
As part of its Speaking Out video series, CURE talked to Dr. Brian Keith McNeil, on behalf of ZERO Prostate Cancer, about navigating treatment option in prostate cancer. Advancements in prostate ...
"Our findings open avenues for biomarkers of therapy response and acquired drug resistance to help guide clinical decisions in individual patients with metastatic prostate cancer throughout the course ...
A PHASE 1/2 clinical trial has reported encouraging early outcomes for single-fraction stereotactic body radiotherapy (SBRT) ...
Association of cardiovascular outcomes with GnRH agonist and antagonist therapy in non-metastatic prostate cancer. Addition of 18F-DCFPyL PSMA PET to MRI to avoid unnecessary biopsy in men on active ...
Combining the principles of evolution with artificial intelligence (AI), scientists have proposed a new way to predict the chance of prostate cancer returning. In a recent study, they harnessed ...
Extracellular vesicles shed by prostate cancer cells to the bloodstream contain tumor-derived material that can be used as biomarkers of therapy response and resistance in patients with metastatic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results